Clinical adverse effects of sodium-glucose cotransporter 2 inhibitors: Protocol for a systematic review and meta-analysis

BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a novel class of oral antidiabetic drugs, which mainly increase urinary glucose excretion through reducing renal glucose reabsorption. There is still a concern about the overall safety profile of SGLT2 inhibitors. In this systematic r...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hao, Shi, Fang-Hong, Huang, Shi-Ying, Zhang, Shun-Guo, Gu, Zhi-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133482/
https://www.ncbi.nlm.nih.gov/pubmed/30095664
http://dx.doi.org/10.1097/MD.0000000000011853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6133482/
https://www.ncbi.nlm.nih.gov/pubmed/30095664
http://dx.doi.org/10.1097/MD.0000000000011853

Ejemplares similares